Stockscreener 앱 받기
6.045
1.23%
-0.075
전일 마감가:
$6.12
열려 있는:
$6.15
하루 거래량:
21,514
Relative Volume:
0.45
시가총액:
$173.01M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.81%
1개월 성능:
+80.45%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$5.80
$6.19
1주일 범위
$5.50
$6.31
52주 변동 폭
$2.33
$6.76
Insight Molecular Diagnostics Inc Stock (IMDX) Company Profile
명칭
Insight Molecular Diagnostics Inc
전화
949-409-7600
주소
2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE
IMDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMDX
Insight Molecular Diagnostics Inc
|
6.045 | 175.15M | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
564.83 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.75 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
720.38 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.88 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
212.27 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Insight Molecular Diagnostics Inc Stock (IMDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-28 | 개시 | Lake Street | Buy |
| 2022-05-24 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-03-14 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-03-17 | 재개 | Needham | Buy |
| 2021-01-07 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-16 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2020-11-30 | 개시 | BTIG Research | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-07-30 | 재확인 | The Benchmark Company | Speculative Buy |
| 2020-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-06-30 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2020-06-02 | 개시 | Needham | Buy |
| 2019-02-13 | 개시 | Piper Jaffray | Overweight |
| 2019-01-29 | 업그레이드 | Janney | Neutral → Buy |
| 2018-12-19 | 재개 | Lake Street | Buy |
모두보기
Insight Molecular Diagnostics Inc 주식(IMDX)의 최신 뉴스
iMDx to Release Third Quarter 2025 Results on November 10 and Attend Stephens Annual Investment Conference the Following Week - The Manila Times
iMDx (NASDAQ: IMDX) schedules Q3 results for Nov 10, to attend Stephens conference - Stock Titan
What MACD trends signal for Insight Molecular Diagnostics Inc. (7OC0) stockEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Is Insight Molecular Diagnostics Inc. (7OC0) stock a buy for dividend portfoliosWeekly Loss Report & Safe Capital Growth Tips - newser.com
Will Insight Molecular Diagnostics Inc. (7OC0) stock boost dividends furtherPortfolio Risk Report & Weekly High Potential Stock Alerts - newser.com
U.S., Europe, and Asia Pacific Molecular Diagnostics Market - openPR.com
Is Insight Molecular Diagnostics Inc. (7OC0) stock included in top ETFs2025 EndofYear Setup & Daily Growth Stock Investment Tips - newser.com
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), TransMedics Group (TMDX) and Opko Health (OPK) - The Globe and Mail
Insight Molecular Diagnostics Advances Kidney Transplant Monitoring with New Study - TipRanks
Is Insight Molecular Diagnostics Inc. (7OC0) stock dividend growth reliablePortfolio Update Report & Weekly Setup with High ROI Potential - newser.com
On the Move: Oct. 21, 2025 - Nashville Post
BillionToOne IPO (BLLN.US): Unique Financial Profile For Molecular Diagnostics Company, Strong Buy - Smartkarma
US Market Wrap: What earnings margins imply for Insight Molecular Diagnostics Inc. (7OC0) stockWeekly Investment Summary & Technical Buy Zone Confirmation - Trung tâm Dự báo KTTV quốc gia
What earnings margins imply for Insight Molecular Diagnostics Inc. (7OC0) stock2025 Bull vs Bear & Comprehensive Market Scan Insights - Trung tâm Dự báo KTTV quốc gia
Returns Recap: Will Insight Molecular Diagnostics Inc. (7OC0) stock maintain strong growthWeekly Risk Report & Consistent Profit Trade Alerts - Trung tâm Dự báo KTTV quốc gia
Insight Molecular Diagnostics names Steven Tahmooressi as VP, marketing - Medical Buyer
Insight Molecular Diagnostics appoints Steven Tahmooressi as VP of Marketing - Investing.com Nigeria
Imdx welcomes new VP Marketing to prepare for commercial transplant assay launch - MarketScreener
iMDx Welcomes New VP Marketing to Prepare for Commercial Transplant Assay Launch - GlobeNewswire
Will Insight Molecular Diagnostics Inc. (7OC0) stock attract long term capital inflowsQuarterly Profit Report & Accurate Technical Buy Alerts - newser.com
Bullish Insight Molecular Diagnostics Insiders Rewarded As Their Investment Rises To US$4.85m - simplywall.st
Insight Molecular Diagnostics Inc.'s (NASDAQ:IMDX) large hedge funds owners must be happy as stock continues to impress, up 12% over the past week - Yahoo Finance
iMDx Reports Kidney Transplant Patient Achieved ‘Immune Reset’ with Novel Therapy and GraftAssure Monitoring - Sahm
Insight Molecular Diagnostics stock rises after transplant study publication - Investing.com
Insight Molecular Says GraftAssure Assay Helped Avoid Overtreatment in Kidney Transplant Patient - MarketScreener
IMDX's GraftAssure Assay Shows Promise in Kidney Transplant Moni - GuruFocus
Insight Molecular Diagnostics Inc (IMDX) 재무 분석
Insight Molecular Diagnostics Inc (IMDX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.94%
6.21%
자본화:
|
볼륨(24시간):